239 related articles for article (PubMed ID: 25793577)
1. Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.
Berndt A; Richter P; Kosmehl H; Franz M
Cell Adh Migr; 2015; 9(1-2):105-11. PubMed ID: 25793577
[TBL] [Abstract][Full Text] [Related]
2. Tenascin-C: Form versus function.
Giblin SP; Midwood KS
Cell Adh Migr; 2015; 9(1-2):48-82. PubMed ID: 25482829
[TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of oncofetal fibronectin and tenascin-C incorporation in tumour vessels using human recombinant SIP format antibodies.
Berndt A; Köllner R; Richter P; Franz M; Voigt A; Berndt A; Borsi L; Giavazzi R; Neri D; Kosmehl H
Histochem Cell Biol; 2010 Apr; 133(4):467-75. PubMed ID: 20237793
[TBL] [Abstract][Full Text] [Related]
4. Fibrillary co-deposition of laminin-5 and large unspliced tenascin-C in the invasive front of oral squamous cell carcinoma in vivo and in vitro.
Berndt A; Borsi L; Hyckel P; Kosmehl H
J Cancer Res Clin Oncol; 2001 May; 127(5):286-92. PubMed ID: 11355143
[TBL] [Abstract][Full Text] [Related]
5. Complex formation of the laminin-5 gamma2 chain and large unspliced tenascin-C in oral squamous cell carcinoma in vitro and in situ: implications for sequential modulation of extracellular matrix in the invasive tumor front.
Franz M; Hansen T; Richter P; Borsi L; Böhmer FD; Hyckel P; Schleier P; Katenkamp D; Zardi L; Kosmehl H; Berndt A
Histochem Cell Biol; 2006 Jul; 126(1):125-31. PubMed ID: 16344911
[TBL] [Abstract][Full Text] [Related]
6. Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
Booth C; Harnden P; Selby PJ; Southgate J
J Pathol; 2002 Nov; 198(3):359-68. PubMed ID: 12375269
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.
Berndt A; Anger K; Richter P; Borsi L; Brack S; Silacci M; Franz M; Wunderlich H; Gajda M; Zardi L; Neri D; Kosmehl H
J Cancer Res Clin Oncol; 2006 Aug; 132(8):537-46. PubMed ID: 16788848
[TBL] [Abstract][Full Text] [Related]
8. Tenascin-C matrix assembly in oral squamous cell carcinoma.
Ramos DM; Chen B; Regezi J; Zardi L; Pytela R
Int J Cancer; 1998 Mar; 75(5):680-7. PubMed ID: 9495234
[TBL] [Abstract][Full Text] [Related]
9. A quantitative co-localization analysis of large unspliced tenascin-C(L) and laminin-5/gamma2-chain in basement membranes of oral squamous cell carcinoma by confocal laser scanning microscopy.
Franz M; Hansen T; Borsi L; Geier C; Hyckel P; Schleier P; Richter P; Altendorf-Hofmann A; Kosmehl H; Berndt A
J Oral Pathol Med; 2007 Jan; 36(1):6-11. PubMed ID: 17181735
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN modulates migration and deposition of TN-C in oral squamous carcinoma.
Dang D; Atakilit A; Ramos DM
Anticancer Res; 2008; 28(4B):2049-54. PubMed ID: 18751374
[TBL] [Abstract][Full Text] [Related]
11. Stromal fibroblasts influence oral squamous-cell carcinoma cell interactions with tenascin-C.
Ramos DM; Chen BL; Boylen K; Stern M; Kramer RH; Sheppard D; Nishimura SL; Greenspan D; Zardi L; Pytela R
Int J Cancer; 1997 Jul; 72(2):369-76. PubMed ID: 9219848
[TBL] [Abstract][Full Text] [Related]
12. The interaction of tenascin-C with fibronectin modulates the migration and specific metalloprotease activity in human mesothelioma cell lines of different histotype.
Giuffrida A; Scarpa S; Birarelli P; Modesti A
Int J Oncol; 2004 Sep; 25(3):745-50. PubMed ID: 15289878
[TBL] [Abstract][Full Text] [Related]
13. Tenascin-C and integrins in cancer.
Yoshida T; Akatsuka T; Imanaka-Yoshida K
Cell Adh Migr; 2015; 9(1-2):96-104. PubMed ID: 25793576
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of Tenascin in embryogenesis, tumorigenesis and inflammatory oral mucosa.
Mane DR; Kale AD; Naik VV
Arch Oral Biol; 2011 Jul; 56(7):655-63. PubMed ID: 21208610
[TBL] [Abstract][Full Text] [Related]
15. B domain containing Tenascin-C: a new urine marker for surveillance of patients with urothelial carcinoma of the urinary bladder?
Gecks T; Junker K; Franz M; Richter P; Walther M; Voigt A; Neri D; Kosmehl H; Wunderlich H; Kiehntopf M; Berndt A
Clin Chim Acta; 2011 Oct; 412(21-22):1931-6. PubMed ID: 21763295
[TBL] [Abstract][Full Text] [Related]
16. IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC).
Richter P; Junker K; Franz M; Berndt A; Geyer C; Gajda M; Kosmehl H; Berndt A; Wunderlich H
J Cancer Res Clin Oncol; 2008 Oct; 134(10):1059-65. PubMed ID: 18386055
[TBL] [Abstract][Full Text] [Related]
17. TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT.
Zhuang J; Lu Q; Shen B; Huang X; Shen L; Zheng X; Huang R; Yan J; Guo H
Sci Rep; 2015 Jul; 5():11924. PubMed ID: 26152796
[TBL] [Abstract][Full Text] [Related]
18. A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Salmas M; Malamou-Mitsi V
BJU Int; 2005 Mar; 95(4):655-9. PubMed ID: 15705098
[TBL] [Abstract][Full Text] [Related]
19. Tenascin: growth and adhesion modulation--extracellular matrix degrading function: an in vitro study.
Shrestha P; Sumitomo S; Lee CH; Nagahara K; Kamegai A; Yamanaka T; Takeuchi H; Kusakabe M; Mori M
Eur J Cancer B Oral Oncol; 1996 Mar; 32B(2):106-13. PubMed ID: 8736172
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of extracellular matrix components tenascin, fibronectin, collagen type IV and laminin in breast cancer: their prognostic value and role in tumour invasion and progression.
Ioachim E; Charchanti A; Briasoulis E; Karavasilis V; Tsanou H; Arvanitis DL; Agnantis NJ; Pavlidis N
Eur J Cancer; 2002 Dec; 38(18):2362-70. PubMed ID: 12460779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
